EUVIMEDEUVIMED entdecken
Crossref

Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease

Guorong Tao, Xuebao Wang, Jian Wang, Yiru Ye, Minxue Zhang, Yan Lang, Saidan Ding iD

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.17373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Guorong Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Animal Center, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Alzheimer Disease, NLR Family, Pyrin Domain-Containing 3 Protein, Resveratrol, Mitophagy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Dihydro‐resveratrol (DHR), a polyphenol derivative, that has been demonstrated to suppress inflammation‐mediated injury. However, it is still unknown whether it has anti‐neuroinflammatory and neuroprotective effects, and a therapeutic action in Alzheimer's disease (AD). Experimental approach The anti‐inflammatory and anti‐Alzheimer's disease actions of dihydro‐resveratrol were investigated using lipopolysaccharide (LPS) and AD mice models, and primary microglial cells. The changes in behaviour in mice were detected by the Morris water maze test and open‐field test. Flow cytometry assay, western blotting, immunofluorescence assays and co‐immunoprecipitation were used to investigate the changes in the NLRP3 inflammasome activation and mitophagy. Key Results In this study, in vivo observations indicated that the administration of dihydro‐resveratrol (DHR) dramatically restored spatial learning, memory ability, autophagy and mitophagy, attenuated NLRP3 inflammasome activation, neuroinflammation and amyloid precursor protein pathology in LPS mice and AD mice. In addition, the inhibition of autophagy and mitophagy, or the activation of NLRP3 in vivo greatly abolished DHR‐generated therapeutic efficacy on neuroinflammation, amyloid precursor protein pathology and cognitive loss. Further examination indicated that the application of DHR after the LPS and ATP exposure significantly inhibited the NLRP3 inflammasome activation, neuroinflammation and enhanced autophagic and mitophagic activation in microglia. Additionally, in vitro results show that DHR protects microglial cells against LPS and ATP‐induced cytotoxicity by inhibiting NLRP3 inflammasome through activating Bnip3‐dependent mitophagy and ULK phosphorylation. Conclusions and Implications In summary, these findings suggest that dihydro‐resveratrol (DHR) possesses potent anti‐neuroinflammatory property and can act as a potential therapeutic agent for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNLR Family, Pyrin Domain-Containing 3 ProteinResveratrolMitophagyMembrane ProteinsInflammasomesMice, Inbred C57BLAnimalsMiceMaleLipopolysaccharidesMitochondrial ProteinsNeuroinflammatory DiseasesMicroglia

Stichwörter der Autor:innen

Alzheimer's diseaseautophagydihydro‐resveratrolinflammationmitophagy

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinResveratrolMembrane ProteinsInflammasomesNlrp3 protein, mouseBNip3 protein, mouseLipopolysaccharidesMitochondrial Proteins

Autor:innen und Institutionen

  • Laboratory Animal Center, Fudan University, Shanghai, China.
  • Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Central Laboratory, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Huangshi Love & Health Hospital, Hubei Polytechnic University, Huangshi, China.

ORCID-Profile: Saidan Ding

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Tao, G., Wang, X., Wang, J., Ye, Y., Zhang, M., Lang, Y., & Ding, S. (2025). Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease. British Journal of Pharmacology. https://doi.org/10.1111/bph.17373

Vancouver

Tao G, Wang X, Wang J, Ye Y, Zhang M, Lang Y, et al. Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease. British Journal of Pharmacology. 2025. doi:10.1111/bph.17373

BibTeX
@article{Tao2025,
  author = {Tao, Guorong and Wang, Xuebao and Wang, Jian and Ye, Yiru and Zhang, Minxue and Lang, Yan and Ding, Saidan},
  title = {Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.17373}
}
Kostenlos starten →